FK-614

DB12557InvestigationalSmall molecule

FK614 has been used in trials studying the treatment of Diabetes Mellitus.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor gamma
Curator reviewed
Formula / weight: C₂₁H₂₃Cl₂N₃O₃S · 468.39 g/mol (avg)
Code names: FK614

Resolves to

Compound

Structure

InChIKeyUYGZODVVDUIDDQ-UHFFFAOYSA-NSMILESCCCCCS(=O)(=O)NC(=O)C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C=C3Cl)C2=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with FK-614, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.